cd31 staining Search Results


90
American Histolabs Inc cd31+ staining
Cd31+ Staining, supplied by American Histolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd31+ staining/product/American Histolabs Inc
Average 90 stars, based on 1 article reviews
cd31+ staining - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
AngioScore Inc cd31 biomarker
Cd31 Biomarker, supplied by AngioScore Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd31 biomarker/product/AngioScore Inc
Average 90 stars, based on 1 article reviews
cd31 biomarker - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
TCS Cellworks cd31 (pecam-1) staining kit
Cd31 (Pecam 1) Staining Kit, supplied by TCS Cellworks, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd31 (pecam-1) staining kit/product/TCS Cellworks
Average 90 stars, based on 1 article reviews
cd31 (pecam-1) staining kit - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
SAS institute immunohistochemical staining of pcna and cd31
Honokiol markedly decreases the immunohistochemical staining of PCNA and <t>CD31</t> in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control
Immunohistochemical Staining Of Pcna And Cd31, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemical staining of pcna and cd31/product/SAS institute
Average 90 stars, based on 1 article reviews
immunohistochemical staining of pcna and cd31 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology cd-31 stains
Honokiol markedly decreases the immunohistochemical staining of PCNA and <t>CD31</t> in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control
Cd 31 Stains, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd-31 stains/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
cd-31 stains - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
NovoPath Inc sectioning staining (cga/cd31+srfg)
Honokiol markedly decreases the immunohistochemical staining of PCNA and <t>CD31</t> in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control
Sectioning Staining (Cga/Cd31+Srfg), supplied by NovoPath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sectioning staining (cga/cd31+srfg)/product/NovoPath Inc
Average 90 stars, based on 1 article reviews
sectioning staining (cga/cd31+srfg) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
KEYENCE coronal cd 31 antibody-stained sections
Honokiol markedly decreases the immunohistochemical staining of PCNA and <t>CD31</t> in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control
Coronal Cd 31 Antibody Stained Sections, supplied by KEYENCE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/coronal cd 31 antibody-stained sections/product/KEYENCE
Average 90 stars, based on 1 article reviews
coronal cd 31 antibody-stained sections - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc cd31 blood vessel staining antibody
Honokiol markedly decreases the immunohistochemical staining of PCNA and <t>CD31</t> in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control
Cd31 Blood Vessel Staining Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd31 blood vessel staining antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
cd31 blood vessel staining antibody - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc cd31 immunofluorescence staining
Honokiol markedly decreases the immunohistochemical staining of PCNA and <t>CD31</t> in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control
Cd31 Immunofluorescence Staining, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd31 immunofluorescence staining/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
cd31 immunofluorescence staining - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc immunohistochemical staining for cd31
Representative microscopic pictures of <t>CD31</t> <t>immunostaining</t> in B16 and MDA-MB-231 tumors. B16 tumors had blood vessels with irregular, expanded lumens. In the MDA-MB-231 tumor, numerous blood vessels with small round lumens were shown. Quantitative data for the mean vessel density (number of blood vessels per HPF (×40)) showed that MDA-MB-231 tumors tend to have a higher number of blood vessels than B16 tumors (188 ± 75 vs. 80 ± 16; P = 0.070). In contrast, B16 tumors had larger lumen area of the blood vessels than MDA-MB-231 tumors (diameter 34.9 ± 14.7 μm in B16 tumor vs. 17.4 ± 7.9 μm in MDA-MB-231 tumor; **** P ≤ 0.0001). These analyses were performed using unpaired t-test from n = 3 mice for each tumor type.
Immunohistochemical Staining For Cd31, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemical staining for cd31/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
immunohistochemical staining for cd31 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Honokiol markedly decreases the immunohistochemical staining of PCNA and CD31 in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control

Journal: BMC Cancer

Article Title: Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction

doi: 10.1186/s12885-016-2265-6

Figure Lengend Snippet: Honokiol markedly decreases the immunohistochemical staining of PCNA and CD31 in SAS SP xenograft tumor tissue. Immunohistochemistry staining of PCNA and CD31 was performed in the paraffin-embedded tissue sections of tumors from mice treated with or without honokiol (80 mg/kg). a The staining intensity ( brown color ) of PCNA was markedly lower in honokiol-treated group. b The PCNA labeling indexes of control and honokiol-treated groups. c The staining intensity of CD31 (endothelial cell marker) was markedly lower in honokiol-treated group. d The number of CD31 positive microvessel was counted at 200x magnification under a microscope. Significantly reduced microvessel density (MVD)/fields was observed in honokiol-treated group. Data shown are mean ± SD. ** p < 0.01; *** p < 0.001, significant difference vs. control

Article Snippet: Fig. 8 Honokiol markedly decreases the immunohistochemical staining of PCNA and CD31 in SAS SP xenograft tumor tissue.

Techniques: Immunohistochemical staining, Staining, Immunohistochemistry, Labeling, Control, Marker, Microscopy

Representative microscopic pictures of CD31 immunostaining in B16 and MDA-MB-231 tumors. B16 tumors had blood vessels with irregular, expanded lumens. In the MDA-MB-231 tumor, numerous blood vessels with small round lumens were shown. Quantitative data for the mean vessel density (number of blood vessels per HPF (×40)) showed that MDA-MB-231 tumors tend to have a higher number of blood vessels than B16 tumors (188 ± 75 vs. 80 ± 16; P = 0.070). In contrast, B16 tumors had larger lumen area of the blood vessels than MDA-MB-231 tumors (diameter 34.9 ± 14.7 μm in B16 tumor vs. 17.4 ± 7.9 μm in MDA-MB-231 tumor; **** P ≤ 0.0001). These analyses were performed using unpaired t-test from n = 3 mice for each tumor type.

Journal: Magnetic Resonance in Medical Sciences

Article Title: In Vivo and Post-mortem Comparisons of IVIM/Time-dependent Diffusion MR Imaging Parameters in Melanoma and Breast Cancer Xenograft Models

doi: 10.2463/mrms.mp.2023-0078

Figure Lengend Snippet: Representative microscopic pictures of CD31 immunostaining in B16 and MDA-MB-231 tumors. B16 tumors had blood vessels with irregular, expanded lumens. In the MDA-MB-231 tumor, numerous blood vessels with small round lumens were shown. Quantitative data for the mean vessel density (number of blood vessels per HPF (×40)) showed that MDA-MB-231 tumors tend to have a higher number of blood vessels than B16 tumors (188 ± 75 vs. 80 ± 16; P = 0.070). In contrast, B16 tumors had larger lumen area of the blood vessels than MDA-MB-231 tumors (diameter 34.9 ± 14.7 μm in B16 tumor vs. 17.4 ± 7.9 μm in MDA-MB-231 tumor; **** P ≤ 0.0001). These analyses were performed using unpaired t-test from n = 3 mice for each tumor type.

Article Snippet: Immunohistochemical staining for CD31 (1:100 dilution; Cell Signaling Technology, Danvers, MA, USA) was performed using Ventana Discovery XT Autostainer (Ventana medical systems, Tucson, AZ, USA).

Techniques: Immunostaining